Clinical utility of expanded non‐invasive prenatal screening compared with chromosomal microarray analysis in over 8000 pregnancies without major structural anomaly.

MLA

Maya, I., et al. “Clinical Utility of Expanded Non‐invasive Prenatal Screening Compared with Chromosomal Microarray Analysis in over 8000 Pregnancies without Major Structural Anomaly.” Ultrasound in Obstetrics & Gynecology, vol. 61, no. 6, June 2023, pp. 698–704. EBSCOhost, https://doi.org/10.1002/uog.26177.

APA

Maya, I., Salzer Sheelo, L., Brabbing, G. D., Matar, R., Kahana, S., Agmon, F. I., Klein, C., Gurevitch, M., Basel, S. L., & Sagi, D. L. (2023). Clinical utility of expanded non‐invasive prenatal screening compared with chromosomal microarray analysis in over 8000 pregnancies without major structural anomaly. Ultrasound in Obstetrics & Gynecology, 61(6), 698–704. https://doi.org/10.1002/uog.26177

Chicago

Maya, I., L. Salzer Sheelo, Goldstein, D. Brabbing, R. Matar, S. Kahana, Fishman, I. Agmon, C. Klein, M. Gurevitch, Salmon, L. Basel, and Dain, L. Sagi. 2023. “Clinical Utility of Expanded Non‐invasive Prenatal Screening Compared with Chromosomal Microarray Analysis in over 8000 Pregnancies without Major Structural Anomaly.” Ultrasound in Obstetrics & Gynecology 61 (6): 698–704. doi:10.1002/uog.26177.